Tryptophanyl Substitutions in Apomyoglobin Determine Protein Aggregation and Amyloid-like Fibril Formation at Physiological pH*
暂无分享,去创建一个
M. Papa | G. Irace | I. Sirangelo | A. Mezzogiorno | C. Malmo | M. Casillo
[1] A. Fersht,et al. Loss of a metal-binding site in gelsolin leads to familial amyloidosis–Finnish type , 2002, Nature Structural Biology.
[2] J. Kelly,et al. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2+ stabilization , 2001, The EMBO journal.
[3] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[4] Christopher M. Dobson,et al. Amyloid fibrils from muscle myoglobin , 2001, Nature.
[5] C. Yu,et al. Structural Events during the Refolding of an All β-Sheet Protein* , 2001, The Journal of Biological Chemistry.
[6] D. J. Douglas,et al. Methanol-induced conformations of myoglobin at pH 4.0. , 2000, Biochemistry.
[7] R. Casadio,et al. The effect of tryptophanyl substitution on folding and structure of myoglobin. , 2000, European journal of biochemistry.
[8] B. W. Erickson,et al. Betabellins 15D and 16D, de Novo designed beta-sandwich proteins that have amyloidogenic properties. , 2000, Journal of structural biology.
[9] H. Fabian,et al. Conversion of yeast phosphoglycerate kinase into amyloid‐like structure , 2000, Proteins.
[10] C M Dobson,et al. Mutational analysis of the propensity for amyloid formation by a globular protein , 2000, The EMBO journal.
[11] M. Hecht,et al. De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[13] Peter T. Lansbury,et al. Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .
[14] Lars Terenius,et al. A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation* , 1999, The Journal of Biological Chemistry.
[15] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Lansbury. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Glockshuber,et al. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.
[18] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[19] Max F. Perutz,et al. Glutamine repeats and neurodegenerative diseases: molecular aspects. , 1999, Trends in biochemical sciences.
[20] W. Surewicz,et al. Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.
[21] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[22] E. Bismuto,et al. Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate. , 1998, Biochimica et biophysica acta.
[23] R. L. Baldwin,et al. Two forms of the pH 4 folding intermediate of apomyoglobin. , 1998, Journal of molecular biology.
[24] H. Jane Dyson,et al. Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding , 1998, Nature Structural Biology.
[25] R. Pappu,et al. The early folding kinetics of apomyoglobin , 1998, Protein science : a publication of the Protein Society.
[26] R. Dyer,et al. Structural heterogeneity of the various forms of apomyoglobin; Implications for protein folding , 1997, Protein science : a publication of the Protein Society.
[27] P. Wright,et al. Is apomyoglobin a molten globule? Structural characterization by NMR. , 1996, Journal of molecular biology.
[28] Michael S. Kay,et al. Packing interactions in the apomyglobin folding intermediate , 1996, Nature Structural Biology.
[29] J. Kelly,et al. Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.
[30] E. Bismuto,et al. Solvent and thermal denaturation of the acidic compact state of apomyoglobin , 1994, FEBS letters.
[31] P E Wright,et al. Formation of a molten globule intermediate early in the kinetic folding pathway of apomyoglobin. , 1993, Science.
[32] W. L. Jorgensen,et al. Molecular dynamics simulations of the unfolding of apomyoglobin in water. , 1993, Biochemistry.
[33] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[34] E. Bismuto,et al. Salt-induced refolding of myoglobin at acidic pH: molecular properties of a partly folded intermediate. , 1992, Archives of biochemistry and biophysics.
[35] K. Higuchi,et al. Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[36] P E Wright,et al. Structural characterization of a partly folded apomyoglobin intermediate. , 1990, Science.
[37] A. Fink,et al. Phase diagram for acidic conformational states of apomyoglobin. , 1990, Journal of molecular biology.
[38] J. Pettegrew,et al. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[39] R. L. Baldwin,et al. Use of site-directed mutagenesis to destabilize native apomyoglobin relative to folding intermediates. , 1989, Biochemistry.
[40] G. Brayer,et al. Horse heart metmyoglobin. A 2.8-A resolution three-dimensional structure determination. , 1988, The Journal of biological chemistry.
[41] S. Sligar,et al. High-level expression of sperm whale myoglobin in Escherichia coli. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] H. Edelhoch,et al. Spectroscopic determination of tryptophan and tyrosine in proteins. , 1967, Biochemistry.
[44] D. Kirschner,et al. A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding. , 2000, Journal of structural biology.
[45] W. Klunk,et al. Quantifying amyloid by congo red spectral shift assay. , 1999, Methods in enzymology.
[46] D. Selkoe,et al. Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[47] C. Blake,et al. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. , 1997, Advances in protein chemistry.
[48] J T Yang,et al. Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.
[49] F. Teale,et al. Cleavage of the haem-protein link by acid methylethylketone. , 1959, Biochimica et biophysica acta.